Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders
Shang Su(Louisiana State University), Yu Rao(Soochow University), J Wang(Fudan University), Sarat Chandarlapaty(Memorial Sloan Kettering Cancer Center), Zixuan An(Tsinghua University), Wei Wu(Stanford University), Haiteng Deng(Jiaxing University), Haiyan Yang(Wenzhou Medical University), Songbiao Zhu(Jilin University), Qing Li(Memorial Sloan Kettering Cancer Center), Hongying Gao(Tsinghua University), Zimo Yang(University of Electronic Science and Technology of China)
Cited by 197
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis
|Cell Research|2014|1.2k
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578